07 Jan 2001

Posorutin® (Posorutin® Augentropfen) - Deutschland

Updated: 07 Jan 2001


Als Adjuvans bei Retinopathia diabetica, Retina- u. Glaskörperblutungen, subkonjunktivale Blutungen u. Thrombosen.

Posorutin® Description, Presentation and Dosage

Posorutin® Description

Posorutin® Drug Class Description


Posorutin® Drug Description

1 ml enth.: Troxerutin 50 mg.

Posorutin® Generic Name

Posorutin® Augentropfen

Posorutin® Presentation

Posorutin® Presentation


Posorutin® Manufacturer


Related Learning Zones



The Hypogonadism Knowledge Centre gives healthcare professionals free access to resources on the diagnosis, treatment and monitoring of patients with the condition. The regularly-updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Posorutin® Dosage

Posorutin® Adult Dosage

Chlorhexidindigluconat 0,05 mg (Konservierungsmittel), Natriumchlorid, Dinatriumedetat, Wasser f. Inj.-zwecke.

Posorutin® Precautions, Reactions and Contraindications

Posorutin® Special Precautions

Related Drugs - Eye Health and Disorders

Back to top